• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南方研究所使用氮烯咪胺(NSC - 45388)进行的实验研究。

Experimental studies at Southern Research Institute with DTIC (NSC-45388).

作者信息

Montgomery J A

出版信息

Cancer Treat Rep. 1976 Feb;60(2):125-34.

PMID:1260770
Abstract

Several years ago the diazotization of 5-aminoimidazole-4-carboxamide was found to give an internal diazonium salt, 5-diazoimidazole-4-carboxamide, which demonstrated marginal activity against some murine neoplasms. In an effort to improve this activity and develop a clinically useful agent, this compound was converted to a number of derivatives including DTIC, an agent that showed encouraging activity against a variety of rodent neoplasms. Studies carried out at Southern Research Institute on the chemistry, metabolism, and biologic activity of DTIC and its congeners are discussed briefly.

摘要

几年前,人们发现5-氨基咪唑-4-甲酰胺重氮化可生成一种内重氮盐,即5-重氮咪唑-4-甲酰胺,它对某些小鼠肿瘤显示出微弱活性。为了提高这种活性并开发一种临床上有用的药物,该化合物被转化为多种衍生物,包括达卡巴嗪(DTIC),这是一种对多种啮齿动物肿瘤显示出令人鼓舞活性的药物。本文简要讨论了南方研究所对达卡巴嗪及其同类物的化学、代谢和生物活性所进行的研究。

相似文献

1
Experimental studies at Southern Research Institute with DTIC (NSC-45388).南方研究所使用氮烯咪胺(NSC - 45388)进行的实验研究。
Cancer Treat Rep. 1976 Feb;60(2):125-34.
2
Antitumor activity of DTIC (NSC-45388) in animals.氮烯咪胺(NSC - 45388)在动物体内的抗肿瘤活性。
Cancer Treat Rep. 1976 Feb;60(2):135-40.
3
[DTIC in malignant melanoma: a perspective (author's transl)].[二氯二苯醚菊酯在恶性黑色素瘤中的应用:一种观点(作者译)]
Wien Klin Wochenschr. 1978 Dec 22;90(24):870-4.
4
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas.氮烯咪胺(NSC - 45388)在肉瘤化疗中的作用。
Cancer Treat Rep. 1976 Feb;60(2):199-203.
5
Carcinogenicity of the antineoplastic agent, 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide, and its metabolites in rats.抗肿瘤药物5-(3,3-二甲基-1-三氮烯基)-咪唑-4-甲酰胺及其代谢产物对大鼠的致癌性。
J Natl Cancer Inst. 1975 Apr;54(4):951-7.
6
In vitro activation of dacarbazine (DTIC) for a human tumor cloning system.达卡巴嗪(DTIC)在人肿瘤克隆系统中的体外激活。
Int J Cell Cloning. 1983 Apr;1(1):24-32. doi: 10.1002/stem.5530010105.
7
Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.新型蒽基双腙9,10-蒽二甲醛双[(4,5-二氢-1H-咪唑-2-基)腙]二盐酸盐对小鼠实验性肿瘤的活性
Cancer Res. 1982 Feb;42(2):440-4.
8
Clinical studies with DTIC (NSC-45388) in various malignancies.用达卡巴嗪(NSC - 45388)对各种恶性肿瘤进行的临床研究。
Cancer Treat Rep. 1976 Feb;60(2):213-4.
9
DTIC (NSC-45388) in malignant melanoma: a perspective.达卡巴嗪(NSC-45388)在恶性黑色素瘤中的应用:综述
Cancer Treat Rep. 1976 Feb;60(2):165-76.
10
Studies on the mechanism of action of DTIC (NSC-45388).氮烯咪胺(NSC - 45388)作用机制的研究。
Cancer Treat Rep. 1976 Feb;60(2):141-8.

引用本文的文献

1
A phase I clinical and pharmacological profile of dacarbazine with autologous bone marrow transplantation in patients with solid tumors.达卡巴嗪联合自体骨髓移植治疗实体瘤患者的I期临床及药理学研究
Invest New Drugs. 1993 May-Aug;11(2-3):169-79. doi: 10.1007/BF00874151.
2
Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules.达卡巴嗪(DTIC)及其代谢产物5-氨基咪唑-4-甲酰胺(AIC)在不同给药方案后的药代动力学。
Cancer Chemother Pharmacol. 1982;9(2):103-9. doi: 10.1007/BF00265388.
3
Altered response to dacarbazine by murine melanoma cells cultured in type I collagen gel.
Arch Dermatol Res. 1990;282(4):278-9. doi: 10.1007/BF00371652.